NCT01737255View on ClinicalTrials.gov

Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome

CompletedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2017

Conditions
Li-Fraumeni Syndrome
Interventions
OTHER

Whole body MRI

Individuals will undergo whole body and brain MRI

OTHER

Psychological questionnaires

All recruits will complete questionnaires at 6 time points to assess psychological impact

Trial Locations (1)

SM2 5PT

Cancer Genetics Unit, Royal Marsden Hospital, Sutton

Sponsors

Collaborators (1)

Cancer Research UK
All Listed Sponsors
collaborator

Cancer Research UK

OTHER

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Institute of Cancer Research, United Kingdom

OTHER

NCT01737255 - Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome | Biotech Hunter | Biotech Hunter